PharmaCyte Biotech, Inc.(NASDAQ : PMCB)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Pharmaceuticals Other
|VRX||Valeant Pharmaceuticals International, Inc.||-0.72%||6.90||14.1%||$40.60m|
|BRBR||BellRing Brands, Inc.||1.10%||20.63||0.0%||$19.75m|
|RVMD||Revolution Medicines, Inc.||0.87%||19.72||0.0%||$18.36m|
|BGXX||Bright Green Corp.||-9.24%||1.08||0.0%||$5.91m|
|USNA||USANA Health Sciences, Inc.||-1.41%||56.05||4.2%||$3.67m|
|ANIK||Anika Therapeutics, Inc.||1.67%||23.80||9.7%||$2.13m|
|MTP||Midatech Pharma Plc||-2.68%||1.87||0.0%||$0.43m|
|ENVB||Enveric Biosciences, Inc.||-2.09%||4.22||0.0%||$0.38m|
|FLGC||Flora Growth Corp.||3.01%||0.71||0.0%||$0.32m|
|NATR||Nature's Sunshine Products, Inc.||-0.84%||8.24||0.4%||$0.32m|
|GHSI||Guardion Health Sciences, Inc.||0.36%||0.14||0.0%||$0.21m|
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.